Abstract Hypertrophic cardiomyopathy (HCM) is characterized by asymmetric septal hypertrophy and is often caused by mutations in MYBPC3 gene encoding cardiac myosin-binding protein C. In contrast to humans, who are already affected at the heterozygous state, mouse models develop the phenotype mainly at the homozygous state. Evidence from cell culture work suggested that altered proteasome function contributes to the pathogenesis of HCM. Here we tested in two heterozygous Mybpc3-targeted mouse models whether adrenergic stress unmasks a specific cardiac phenotype and proteasome dysfunction. The first model carries a human Mybpc3 mutation (Het-KI), the second is a heterozygous Mybpc3 knock-out (Het-KO). Both models were compared to wild-type (WT) mice. Mice were treated with a combination of isoprenaline and phenylephrine (ISO/PE) or NaCl for 1 week. Whereas ISO/PE induced left ventricular hypertrophy (LVH) with increased posterior wall thickness to a similar extent in all groups, it increased septum thickness only in Het-KI and Het-KO.
Introduction
Hypertrophic cardiomyopathy (HCM) is a myocardial disease with the major feature of asymmetric septal hypertrophy (Elliott et al. 2008; Richardson et al. 1996) . It is considered as the most prevalent cause of sudden cardiac death, particularly in young athletes during exercise without precedent symptoms, and is associated with a significant risk of heart failure (Maron 2002) . HCM is transmitted as an autosomal-dominant trait with an incomplete penetrance (Charron et al. 1997 ) and involves more than 500 mutations in 19 different genes encoding sarcomeric proteins (for recent reviews, see Ashrafian et al. 2011; Seidman and Seidman 2011) . The two most frequently mutated genes are MYH7 and MYBPC3 encoding b-myosin heavy chain (b-MHC) and cardiac myosin-binding protein C (cMyBP-C), respectively. cMyBP-C is a component of the thick filaments, located in doublets in the C-Zone of the A-Band of the sarcomere, and exclusively expressed in the heart in mammals (Fougerousse et al. 1998; Gautel et al. 1998) . A significant body of evidence indicates both structural and functional roles of cMyBP-C in the cardiac sarcomere (for reviews, see Barefield and Sadayappan 2010; . Particularly, we and others have shown that cMyBP-C acts as a physical restrain on the myosin heads, thus reducing the probability of their interaction with actin during diastole (Colson et al. 2007; Pohlmann et al. 2007 ). One of the specific features of cMyBP-C is the presence of four phosphorylation sites (for a recent review, see Barefield and Sadayappan 2010), which are regulated through different kinases such as cAMP-dependent protein kinase (PKA; Gautel et al. 1995) , protein kinase D (PKD; Bardswell et al. 2010 ) and p90 ribosomal S6 kinase (Cuello et al. 2011) , as well as by intracellular Ca 2? levels via the Ca 2? /calmodulin kinase II (McClellan et al. 2001) . Phosphorylation of cMyBP-C has been shown to affect myofilament Ca 2? sensitivity, myocardial function, and cardiac metabolism (Cazorla et al. 2006; Decker et al. 2005; McClellan et al. 2004; McClellan et al. 2001; Sadayappan et al. 2005 Sadayappan et al. , 2006 .
Most of the MYBPC3 mutations are either frameshift or nonsense mutations, and were supposed to produce C-terminal truncated proteins . However, truncated proteins were never detected in myocardial tissue of patients with MYBPC3 mutations (Marston et al. 2009; Moolman et al. 2000; Rottbauer et al. 1997; van Dijk et al. 2009 ). Analyses of cardiac myocytes expressing mutant MYBPC3 or Mybpc3-targeted knock-in (KI) mice using specific inhibitors provided evidence that mutant cMyBP-Cs are degraded by the ubiquitin-proteasome system (UPS; Bahrudin et al. 2008; Flavigny et al. 1999; Mearini et al. 2010; Sarikas et al. 2005; Vignier et al. 2009 ). Importantly, degradation of mutant cMyBP-Cs was associated with UPS saturation after gene transfer in cardiac myocytes (Bahrudin et al. 2008; Sarikas et al. 2005) . The UPS is a major proteolytic system in cells, which degrades most cellular, nuclear and myofibrillar proteins. A main function of the UPS is to prevent accumulation of damaged, misfolded and mutant proteins. It is an ATP-dependent system that requires polyubiquitination of the target protein prior to its degradation by the 26S proteasome (for review, see Ciechanover 2006) . A number of studies have outlined the functional significance of the UPS in cardiovascular physiology and disease, including UPS activation or repression in experimental models of hypertrophy and heart failure (for reviews, see Carrier et al. 2010; Gomes et al. 2006; Hedhli and Depre 2010; Mearini et al. 2008; Portbury et al. 2011; Su and Wang 2010; Willis et al. 2010) .
In contrast to patients with HCM, who are already affected at the heterozygous state, several mouse models of HCM develop a phenotype mainly or exclusively at the homozygous state (Geisterfer-Lowrance et al. 1996; Harris et al. 2002; Vignier et al. 2009 ). For instance in a Mybpc3-targeted knock-out mouse model lacking the exons 3-10, only the homozygous mice showed a HCM phenotype with contractile dysfunction, whereas the heterozygous mice were indistinguishable from wild-type (WT) littermates (Harris et al. 2002) . Patients carrying the Arg403Gln MYH7 mutation have a markedly shortened life expectancy (Geisterfer-Lowrance et al. 1990) , which is mirrored in homozygous a-MHC 403/403 mice, which died by day 7 after birth, but not in heterozygous a-MHC 403/? mice, which display a normal survival (Geisterfer-Lowrance et al. 1996) . Similarly, the Arg258Lys MYBPC3 mutation, associated with a severe phenotype and bad prognosis in human at the heterozygous state (Richard et al. 2003) , did not result in a phenotype in Mybpc3-targeted knock-in mice at the heterozygous state while the homozygotes exhibited left ventricular hypertrophy, reduced fractional shortening and interstitial fibrosis (Vignier et al. 2009) . A reason for the discrepancy between humans and mice may be the different levels of stress. While humans are generally exposed to a plethora of external stress factors, mice in cages supposedly have a relatively sedentary and stressfree lifestyle. In the present study, we subjected two different heterozygous Mybpc3-targeted mouse models to prolonged adrenergic stimulation to evaluate whether this could unmask a functional and/or molecular cardiac phenotype. The reasoning behind choosing the two models was as follows. Heterozygous knock-in (Het-KI) mice carry a frequent human Mybpc3 point mutation and exhibit not only less WT cMyBP-C than WT mice (Vignier et al. 2009 ), but also express low levels of mutant cMyBP-C which we had shown previously to cause proteasome dysfunction in cultured myocytes (Sarikas et al. 2005) . Heterozygous knock-out (Het-KO) mice, in contrast, exhibit only haploinsufficiency ).
Methods
The investigation conforms to the guide for the care and use of laboratory animals published by the NIH (Publication No. 85-23, revised 1985) .
Animal models
Creation and initial characterizations of Mybpc3-targeted KI and KO mice were previously reported Vignier et al. 2009 ). In brief, both models were generated by targeted transgenesis of Mybpc3 gene by homologous recombination in ES cells. Het-KI mice carry a G[A transition on the last nucleotide of exon 6 on one allele (Vignier et al. 2009 ; Fig. 1A ). The Het-KO model was based upon the targeted deletion of exons 1 and 2, which contain the transcription initiation site, resulting in only one functional WT allele ; Fig. 1A ). Both mouse lines and the WT mice, which were used as controls, were maintained on the Black Swiss genetic background.
Administration of a-and b-adrenergic agonists Isoprenaline and phenylephrine (both from Sigma) were delivered to mice by subcutaneously implanted osmotic minipumps (Alzet, model 1007D) that released both substances in 0.9% NaCl for 1 week at a dose of 15 mg/kg per day each. Control pumps delivered 0.9% NaCl solution alone. Anaesthesia was performed with isoflurane (1.5 vol%). The pumps were incubated in 0.9% NaCl at 37°C overnight to achieve the full pumping rate from the beginning.
Echocardiography
Mouse transthoracic echocardiography was performed using a Visual Sonics Vevo 770 Ò ultrasonograph with a 30 MHz single crystal mechanical transducer. Mice were kept under ECG-controlled anaesthesia with 0.5-1 vol% isoflurane (Abbott Inc.). Two-dimensional echocardiography images were obtained in a modified parasternal shortaxis view at mid-papillary muscle level. Mutant-2, 32 kDa, n.d.
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Het-KO Fig. 1 Consequences of Mybpc3 targeting in Het-KI and Het-KO mice. A Schematic structure of alleles, mRNAs and proteins in Het-KI and Het-KO mice. Het-KI have a WT allele and a mutant allele, which contains a G[A transition on the last nucleotide of exon 6. This results in 50% WT mRNA and less than 2% of both mutant-2 (nonsense) and mutant-3 (deletion/insertion) mRNAs due to the exon 6 skipping (Vignier et al. 2009 ). Mutant-2 contains a premature termination codon (PTC) in exon 9, and is expected to produce a 32 kDa-truncated cMyBP-C, which has not been detected in Het-KI (Vignier et al. 2009 ). Mutant-3 mRNA retains parts of intron 8, which restores the reading frame, and should produce a 147 kDa-cMyBP-C.
Het-KO mice carry only 1 functional WT allele, due to inactivation of the mutant allele by deletion of exons 1 and 2, including the transcription initiation site. This has been shown to result in 50% WTcMyBP-C mRNA after 10 months of age . B Representative Western blots of ventricular crude protein extracts of WT, Het-KI and Het-KO stained with antibodies directed against either the C0-C1 domains of cMyBP-C or the new aminoacids created by the frameshift due to the skipping of exon 6. Levels of cMyBP-C were normalized to Ponceau (note that higher protein quantity were loaded in both Het-KI and Het-KO than in WT). Data are expressed as mean ± SEM. The number of animals is indicated in the bars J Muscle Res Cell Motil (2012) 33:5-15 7 ventricular diameter) were measured in a short axis view in diastole.
Analysis of mRNAs
Total RNA was extracted from mouse ventricles using the SV Total RNA Isolation Kit (Promega) according to the manufacturer's instructions. RNA concentration, purity and quality were determined using the NanoDrop Ò ND-1000 spectrophotometer. RT was performed using oligo-dT primers with the SuperScript TM III First-Strand Synthesis System (Invitrogen) from 100 ng RNA. The quantitative determination of the b5-subunit and G aS mRNAs was performed by qPCR using the Maxima TM SYBR Green/ROX qPCR Master Mix (Fermentas), and primers specific for every mouse sequence. Particularly, the primers used to amplify the b5-subunit were F: 5 0 -GAGCTTCGCAATA AGGAACG-3 0 and R: 5 0 -CTGTTCCCCTCGCTGTCTAC-3 0 and to amplify G aS F: 5 0 -CAAGGCTCTGTGGGAGGAT-3 0 and R: 5 0 -CGAAGCAGGTCCTGGTCACT-3 0 . G aS was used as an endogenous control to normalize the quantification of the target mRNAs for difference in the amount of total RNA added to each reaction. Experiments were performed on the ABI PRISM Ò 7900HT Sequence Detection System (Applied Biosystems). The mRNA amount was estimated according to the comparative Ct method with the 2 -DDCt formula.
Cytosolic and crude protein extracts from ventricular tissue
About 50 mg of mouse ventricular tissue was frozen-thaw three times in 250 ll of H 2 O containing a protease-inhibitor cocktail (complete mini TM , Roche Diagnostics), and homogenized using the Tissue Lyser (2 9 30 s at 20 Hz). Soluble material (cytosolic fraction) was recovered by centrifugation at 13200 rpm for 30 min at 4°C. Crude protein extract was obtained from about 50 mg of ventricular tissue homogenized in 3% SDS, 30 mM Tris-base, pH 8.8, 5 mM EDTA, 30 mM NaF, 10% glycerol and 1 mM DTT and centrifuged at 13200 rpm for 10 min at 20°C. The supernatants were collected and their concentrations were determined using the BioRad protein assay reagent (BioRad).
Western blot analysis
Proteins were loaded on acrylamide/bisacrylamide (29:1) gels and electrotransferred to nitrocellulose membranes with a 0.45 lm-pore size. Membranes were stained overnight with the monoclonal antibody directed against ubiquitin (FK2, Biomol, 1:50000), and the polyclonal antibodies directed against cMyBP-C (C0-C1 domains, 1:1000; frameshift, 1:1000) and the b5-subunit of the proteasome (kindly given by X.J. Wang, University of South Dakota, 1:5000). The secondary antibodies were coupled to HRP (Dianova). Signals were revealed with ECL plus (Amersham) or SuperSignal Ò West Dura extended duration substrate (Pierce) and acquired with the Chemie Genius 2 Bio Imaging System. Quantification of the signal was done using the Gene Tools software.
Determination of the chymotrypsin-like activity
The chymotrypsin-like activitiy of the proteasome was assessed in ventricular cytosolic lysates using the synthetic peptide substrate Suc-LLVY-AMC (60 lM, Merck Biosciences) as described previously (Vignier et al. 2009 ).
Statistical analysis
Data are presented as mean ± SEM. Statistical analyses were performed using the unpaired or paired Student's t-test as indicated in the legends. All analyses were realized using the GraphPad Software Inc. A value of P \ 0.05 was considered statistically significant.
Results

Molecular characterization of Het-KI and Het-KO mice
Both Het-KI and Het-KO have been developed and characterized previously Vignier et al. 2009 ). Het-KI have a WT allele and a mutant allele that contains a G[A transition on the last nucleotide of exon 6, whereas Het-KO exhibited only one functional WT allele due to the inactivation of the other one (Fig. 1A) . The level of total cMyBP-C mRNA has been shown to be 50% lower in both Het-KI and Het-KO than in WT mice, and Het-KI also exhibited a low level of frameshift mutant-2 and mutant-3 mRNAs (\2% each; Fig. 1A ; Carrier et al. 2004; Vignier et al. 2009 ). The level of cMyBP-C proteins was *20% lower in Het-KI and Het-KO than in WT (Fig. 1) . Mutant-3, but not mutant-2 was detected only in Het-KI (Fig. 1B) . It was not well incorporated in the sarcomere but rather found as aggregates in the perinuclear region and the cytosol in cardiac myocytes isolated from Het-KI newborn mice (Fig. S1 ).
Adrenergic stress unmasks septal hypertrophy only in Het-KI and Het-KO mice At the investigated age of 5 months both Het-KI and Het-KO mice exhibited a normal heart-weight-to-bodyweight ratio (HW/BW; Carrier et al. 2004; Vignier et al. 2009 ). To provoke a phenotype mice were treated with a combination of isoprenaline (ISO) and phenylephrine (PE; both 15 mg/kg per day) in 0.9% NaCl. As control, mice were subjected to minipumps delivering 0.9% NaCl solution alone. After 1 week of treatment, the ventricular-weight-tobody-weight (VW/BW) ratio was higher in all groups treated with ISO/PE than with NaCl (?31% in WT, ?20% in Het-KI and ?35% in Het-KO), indicating that ISO/PE induced LVH (Fig. 2A) . Unexpectedly, Het-KI mice exhibited a slightly higher VW/BW upon NaCl than WT (Fig. 2A) .
To get more morphological information about the type of hypertrophy, we also evaluated cardiac dimensions by echocardiography, before minipump implantation and after 1 week of treatment. Overall the change in left ventricular mass-to-body-weight ratio (LVM/BW) induced by adrenergic stress did not differ between the 3 genotypes, although there was a trend towards higher values in Het-KI and Het-KO mice (Fig. 2B) . Similarly, the change in posterior wall thickness in diastole induced by ISO/PE (delta PWThd) did not vary between the genotypes (Fig. 2C) . On the other hand, the ISO/PE-induced change in septum thickness in diastole (delta SepThd) was higher in Het-KO and Het-KI, although non-significant in the latter, than in WT mice (Fig. 2D) . These data suggest that adrenergic stress unmasks septal hypertrophy only in the heterozygous Mybpc3-targeted mice, which both carry only one WT allele.
Adrenergic stress reveals proteasome impairment only in Het-KI mice
We hypothesized that adrenergic stress reveals UPS impairment in Het-KI, which express low levels of mutant cMyBP-Cs, but not in Het-KO mice, which exhibit haploinsufficiency only (Fig. 1) . The UPS function was evaluated by determining steady-state levels of ubiquitinated proteins by Western blot using an antibody directed against ubiquitin and by measuring the chymotrypsin-like activity of the 26S-proteasome using the fluorogenic substrate Suc-LLVY-AMC. Unexpectedly, the steady-state levels of ubiquitinated proteins were already more than 45% higher in Het-KI and Het-KO than in WT mice upon NaCl treatment (Fig. 3A) . ISO/PE induced an increase in ubiquitinated proteins levels by 51% in WT mice, but did not increase them further in heterozygous Mybpc3-targeted mice (Fig. 3A) .
The chymotrypsin-like activity did not differ between Het-KO and WT mice under all conditions. In contrast, it was 16% lower in Het-KI than in WT upon NaCl and 40% lower upon ISO/PE treatment (Fig. 3B) . Since the chymotrypsin-like activity resides in the b5-subunit of the 20S-proteasome, we analyzed its concentration in the cytosolic fraction by Western blot using a specific antibody. Protein levels of the b5-subunit essentially mirrored chymotrypsin activity, i.e. they were 16% lower in Het-KI than in WT upon NaCl and 51% lower upon ISO/PE treatment (Fig. 4A, C) . In contrast, they did not differ between Het-KO and WT and did not change after ISO/PE in these two groups (Fig. 4B, C) . To test whether the changes in Het-KI were due to a global reduction in b5-gene transcription or translation, we determined the protein and transcript levels of the b5-subunit in the crude fraction. The b5-subunit protein and mRNA levels did not differ between Het-KI and WT mice (Fig. 5A, B ). This suggests a specific translocation of the b5-proteasome from the cytosol to another cellular fraction in Het-KI. Protein fractionation indicated a higher amount of b5-subunit in the triton fraction after ISO/PE than NaCl in Het-KI (Fig. S2) . In Het-KI mice, the chymotrypsin-like activity and the level of b5-subunit of the proteasome were both negatively Fig. 4 Evaluation of the b5-subunit protein level in the cytosolic fraction after induction of adrenergic stress in Het-KI, Het-KO, and WT mice. Analyses were performed in ventricular cytosolic protein extracts of Het-KI (light gray), Het-KO (dark gray), and WT (white) mice treated for 1 week with NaCl (hatched) or ISO/PE (plain). Representative Western blots stained with an anti-b5-subunit antibody together with corresponding Ponceau of A WT and Het-KI, and B WT and Het-KO mice. C Levels of b5-subunit protein normalized to Ponceau. Data are expressed as mean ± SEM with ***P \ 0.001 vs. NaCl, and #P \ 0.05 vs. WT, paired and unpaired Student's t-test, respectively. The number of animals is indicated in the bars correlated with the degree of cardiac hypertrophy as determined by the VW/BW ratio. No such correlation was observed in Het-KO or WT mice (Fig. 6A, B) .
Discussion
This study evaluated whether adrenergic stress reveals a specific cardiac phenotype and proteasome dysfunction in two heterozygous Mybpc3-targeted mice that do not develop an apparent cardiac phenotype until the age of 11 months Vignier et al. 2009 ). The major findings were as follows: Adrenergic stress (i) unmasked an HCM phenotype (septal hypertrophy) in both Het-KI and Het-KO mice, which carry only one WT allele, and (ii) revealed proteasome impairment specifically in Het-KI mice, which carry additionally a mutant Mybpc3 allele, and therefore exactly mirror the genetic situation in affected HCM patients. This supports the concept that proteasome impairment contributes to the pathophysiology of HCM, at least in cases associated with MYBPC3 gene mutations. In order to induce chronic adrenergic stress we treated the mice with a combination of the a-adrenergic agonist PE and the b-adrenergic agonist ISO for 1 week. Stimulation of the a1-adrenergic receptor by PE has direct positive inotropic and pro-hypertrophic effects on myocytes that involve small increases in intracellular Ca 2? transients, larger increases in myofilament Ca 2? sensitivity and activation of various protein kinase pathways (Woodcock et al. 2008 ). In addition, PE is a strong vasoconstrictor and thereby increases cardiac afterload. The b-adrenergic agonist ISO has strong cAMP and PKA-dependent positive inotropic and lusitropic actions on the heart and also induces cardiac hypertrophy (Lohse et al. 2003) . In contrast to PE, it dilates blood vessels via b2-adrenergic receptors and thereby decreases afterload. It has been shown that a dose of *30 mg/kg/d of both ISO and PE consistently resulted in marked cardiac hypertrophy after 5-7 days of treatment in mice (Buitrago et al. 2005; Maass et al. 2004; Saadane et al. 1999 Saadane et al. , 2000 . We had expected that Het-KO and Het-KI show an exaggerated response to the treatment. This was not the case globally, but ISO/PE induced septal hypertrophy only in these mice, not in WT. This supports the hypothesis that stress unmasks an HCM phenotype in these mouse models as it has previously been shown for ageing in Het-KO mice . The cause of the specific affection of septum thickness in these models and in human HCM remains uncertain, but the similar response of Het-KI and Het-KO to ISO/PE suggests that a reduced amount of cMyBP-C is sufficient to cause this hallmark of HCM.
Interestingly, Het-KI mice treated with NaCl exhibited a slightly, but significantly higher VW/BW than WT. This could indicate either pre-existing cardiac hypertrophy in Het-KI (which would be in contrast to our own previous data in this mouse line; Vignier et al. 2009) or that the mild stress related to pump implantation had induced the phenotype. The echocardiographic data performed before minipump implantations argue for the second explanation because no differences were observed between Het-KI and WT in this analysis (data not shown).
An increasing body of evidence indicates UPS alterations in human or experimental cardiac disease (for reviews, see Gomes et al. 2006; Hedhli and Depre 2010; Mearini et al. 2008; Portbury et al. 2011; Su and Wang 2010; Willis et al. 2010) . Specifically, we and others reported that cMyBP-C mutants can impair the UPS after gene transfer in cardiac myocytes, suggesting that UPS impairment plays an own pathogenic role in HCM (Bahrudin et al. 2008; Sarikas et al. 2005 ). The present data support this idea in an in vivo setting by demonstrating that adrenergic stress leads to reduced chymotrypsin-like activity in the cytosol specifically in the Het-KI, but not Het-KO or WT mice. The major difference between Het-KI and Het-KO is the presence of a small amount of mutant cMyBP-Cs in Het-KI (Fig. 1B, S1 ), which is lacking in Het-KO. Therefore, the data strongly indicate that the UPS defect is causally related to the presence of the mutant proteins. Our data in the mouse model nicely fit to a recent study showing markedly reduced chymotrypsin-like activities in myocardial tissue from HCM patients, particularly from those with MYBPC3 mutations (Predmore et al. 2010) . The exact mechanism how the presence of mutant cMyBP-Cs could affect proteasome activity remains uncertain. However, the reduction in chymotrypsin-like activity and the level of b5-subunit in the cytosol was associated with and almost certainly due to translocation of the b5-subunit from the cytosol to another cellular compartment, which remains to be identified. The higher levels of b5-subunit in triton-soluble protein fractions (Fig. S2 ) and its diffuse localization in the cytosol and sarcolemma (Fig. S3) after ISO/PE support this hypothesis. Reversible localization of proteasomal components has been observed previously. Yeast cells that stop cell cycling relocate the proteasome from the nucleus to the cytosol into storage granules (Laporte et al. 2008 ). In neurodegenerative disorders, the proteasome is relocalized into intracytoplasmic inclusions (for review, see (Kopito 2000) . Furthermore, proteasome inhibition induces perinuclear aggregates containing proteasome subunits and ubiquitinated proteins (for reviews, see Kopito 2000; Wojcik and DeMartino 2003) . Frameshift mutant-3 cMyBP-C was not well incorporated in the sarcomere, but rather formed aggregates in the perinuclear region and the cytosol in cardiac myocytes from newborn and adult Het-KI mice (Figs. S1, S3 ), suggesting the possibility that it recruits the proteasome to these structures.
In contrast to Het-KI, ISO/PE had no effect on chymotrypsin-like activity or b5-subunit levels in Het-KO or WT, which is in contrast to recent findings of proteasome activation after 1-week treatment of mice with 30 mg/kg/ day of ISO (Drews et al. 2010) . The discrepancy between the two studies is likely explained by different doses of ISO and/or the absence or presence of PE. ISO/PE-induced LVH was associated with a marked increase in the steadystate levels of ubiquitinated proteins in WT mice, consistent with the recent understanding that this parameter indicates cardiac remodeling rather than impairment of UPS (for reviews, see Gomes et al. 2006; Hedhli and Depre 2010; Mearini et al. 2008; Portbury et al. 2011; Su and Wang 2010; Willis et al. 2010) . Unexpectedly, however, the steady-state levels of ubiquitinated proteins were already higher in Het-KI and Het-KO treated with NaCl and did not increase further with ISO/PE. This suggests that these mice, despite not globally sick, already show subtle signs of cardiac affection. Indeed, we have found previously, at younger or similar ages, slight myocyte hypertrophy, which did not translate into an increase in HW/BW ratio in Het-KI mice (Vignier et al. 2009 ) and activation of MAPK signaling pathways as well as upregulation of UPS components, such as E2 ubiquitinconjugated enzymes in Het-KO (Eijssen et al. 2008) . This, together with the stress induced by the minipump implantation, could result in increased protein turnover and higher concentration of ubiquitinated proteins in Het-KI and Het-KO mice.
In conclusion, our data suggest that a reduced amount of cMyBP-C in the heart is sufficient to cause a HCM phenotype under adrenergic stress. The additional presence of low levels of mutant cMyBP-C in Het-KI causes proteasome impairment, which likely contributes to the pathophysiology of HCM associated with MYBPC3 gene mutations.
